NeuBase Therapeutics, Inc. (NBSE)
NASDAQ: NBSE · IEX Real-Time Price · USD
0.434
+0.004 (0.88%)
At close: Mar 28, 2024, 3:01 PM
0.445
+0.011 (2.53%)
After-hours: Mar 28, 2024, 6:46 PM EDT

NeuBase Therapeutics Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for NBSE.

Analyst Consensus: n/a
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

There are currently no analyst ratings available for NBSE.

Recommendation Trends

Rating May '22Jun '22Jul '22Aug '22Sep '22Oct '22
Strong Buy 222220
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 222220

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Oppenheimer
Oppenheimer
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Oct 21, 2022
RBC Capital
RBC Capital
Hold
Downgrades
$240$20
Hold Downgrades $240$20 +4,508.29% Oct 18, 2022
Chardan Capital
Chardan Capital
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Oct 17, 2022
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$180$140
Strong Buy Maintains $180$140 +32,158.06% Aug 12, 2022
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$300$200
Strong Buy Maintains $300$200 +45,982.95% May 31, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-6.53
from -20.80
EPS Next Year
-9.18
from -6.53
Year 20182019202020212022202320242025
Revenue
--------
Revenue Growth
--------
EPS
-92.00-63.20-17.80-18.60-20.80-6.53-9.18-11.63
EPS Growth
--------
No. Analysts -----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202320242025
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 202320242025
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202320242025
High -6.72 -9.45 -11.97
Avg -6.53 -9.18 -11.63
Low -6.27 -8.82 -11.17

EPS Growth

EPS Growth 202320242025
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.